NIH-funded research NIH-funded research

BVES protein in colorectal cancer: stopping tumor spread by stabilizing cell junctions

Official title: Modulation of junctional signaling by BVES in colorectal carcinoma.

Funded at Veterans Health Administration · NIH-11412317 · Data updated 2026-11-12

This grant explores how BVES, a protein at cell junctions, prevents colorectal cancer cells from becoming more aggressive and how restoring BVES could lead to new ways to stop tumor growth.

More Carcinoma research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration
NIH-funded
Lab location1 site (Nashville, United States)
Project startAugust 1, 2026
Project endJuly 31, 2030
Funding year2026
NIH project number2I01RD001496-13A2
Project IDNIH-11412317 on NIH RePORTER

Who could benefit from this research

Could help

Patients with colorectal cancer or those at risk who may benefit from future diagnostics or treatments targeting BVES-related pathways.

Less likely to help

Patients without colorectal cancer or those not influenced by BVES-related mechanisms may not benefit.

What this research studies

Colorectal cancer affects many patients in the U.S., including those treated within the VA system. The project studies BVES, a junctional protein, and its role in suppressing malignant traits in colorectal cancer cells. Researchers are using 3D cell culture and other advanced models to understand how BVES coordinates signaling to keep cells from growing uncontrollably and invading surrounding tissues. The goal is to identify new targets for diagnosis or therapy based on BVES-related pathways. This work builds on prior findings that BVES loss increases tumor burden in animal models, suggesting a tumor-suppressor role that could be leveraged clinically.

Why it matters

Potential benefit: If successful, the work could lead to new biomarkers or therapies that strengthen cell junctions to slow or prevent colorectal cancer progression.

How similar studies have gone: Previous studies show BVES loss is linked to worse colorectal cancer phenotypes and BVES restoration reduces tumor-like behavior in cells.

Where this research is happening

  • Veterans Health Administration
    Nashville, United States
    Active

Researchers

  • Principal investigator: Williams, Christopher S. — Veterans Health Administration
  • Study coordinator: Williams, Christopher S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.